Lys627
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.0.1
Powered by Cell Signaling Technology
Home > Ubiquitylation Site Page: > Lys627  -  RIPK1 (human)

Site Information
ERDGLKEkVYQMLQk   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 2188102

In vivo Characterization
Methods used to characterize site in vivo:
electrophoretic mobility shift ( 4 ) , immunoprecipitation ( 1 ) , mass spectrometry ( 1 , 2 , 4 ) , modification-specific antibody ( 4 ) , multiple reaction monitoring (MRM) ( 4 ) , mutation of modification site ( 1 ) , western blotting ( 1 , 4 )
Relevant cell line - cell type - tissue:

Downstream Regulation
Effects of modification on RIPK1:
enzymatic activity, induced ( 1 ) , ubiquitination ( 1 )
Effects of modification on biological processes:
apoptosis, induced ( 1 )
Induce interaction with:
CASP8 (human) ( 1 ) , FADD (human) ( 1 )

References 

1

Li X, et al. (2020) Ubiquitination of RIPK1 regulates its activation mediated by TNFR1 and TLRs signaling in distinct manners. Nat Commun 11, 6364
33311474   Curated Info

2

Akimov V, et al. (2018) UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol 25, 631-640
29967540   Curated Info

3

Feltham R, et al. (2018) Mind Bomb Regulates Cell Death during TNF Signaling by Suppressing RIPK1's Cytotoxic Potential. Cell Rep
29642005   Curated Info

4

Mollah S, et al. (2007) Targeted mass spectrometric strategy for global mapping of ubiquitination on proteins. Rapid Commun Mass Spectrom 21, 3357-64
17883243   Curated Info